FundedIQ
Biotechnology

Intus Bio: Funding, Investors & Team (Sep 2026)

Intus Bio is utilizing its unique advanced technology to pinpoint bacteria and provide detailed, accurate, and extensive information about the microbiome. They are collaborating with various industries and partners worldwide to conduct innovative research and offer services in health, agriculture, and the environment. Additionally, the company is constantly creating new partnerships, technologies, and uses for its technology.

intusbio.com LinkedIn Farmington, United States 11-50 employees
Bioinformatics Biotechnology Health Care Health Diagnostics B2B
Total raised
$4.2M
Rounds
3
Latest
Undisclosed round
May 2025

Intus Bio has raised $4.2M across 3 funding rounds on record, the most recent an undisclosed round of $1.1M announced in May 2025.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Intus Bio Company Profile and Key Stats

Total funding raised
$4.2M
across 3 rounds on record
Funding rounds on record
3
Latest funding round
Undisclosed round
$1.1M in May 2025
Employees
11-50
reported band
Headquarters
Farmington, United States

Latest funding round on record: May 2025.

Intus Bio Funding Rounds

Date
Round
Amount
Undisclosed round
$1.1M
Undisclosed round
$2.0M
Undisclosed round
$1.1M

Intus Bio raised $1.1M in an undisclosed round announced in Nov 2022.

1.7 years later, an undisclosed round of $2.0M was announced in Jul 2024.

10 months later, an undisclosed round of $1.1M was announced in May 2025.

Intus Bio Founders and Leadership Team

Name
Role
Contact
Mark Driscoll
Founder
Locked
Paul Denslow
Founder
Locked
Thomas Jarvie
Founder

Contact details for the Intus Bio team: 2 of 3 have an email address on file.

Start 14-day free trial →

Intus Bio Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
29,795
$7.5M

Intus Bio's latest round of $1.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Intus Bio in Biotechnology and Farmington

Companies Similar to Intus Bio

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Intus Bio Funding FAQs

What does Intus Bio do?

Intus Bio is utilizing its unique advanced technology to pinpoint bacteria and provide detailed, accurate, and extensive information about the microbiome. They are collaborating with various industries and partners worldwide to conduct innovative research and offer services in health, agriculture, and the environment. Additionally, the company is constantly creating new partnerships, technologies, and uses for its technology.

How much funding has Intus Bio raised?

Intus Bio has raised $4.2M across 3 rounds on record. The most recent is an undisclosed round of $1.1M announced in May 2025.

When did Intus Bio last raise funding?

Intus Bio's most recent funding round on record is an undisclosed round of $1.1M, announced in May 2025.

Who founded Intus Bio?

FundedIQ lists Mark Driscoll (Founder), Paul Denslow (Founder), Thomas Jarvie (Founder) at Intus Bio.

Where is Intus Bio headquartered?

Intus Bio is based in Farmington, Connecticut, United States.

How many employees does Intus Bio have?

Intus Bio is in the 11-50 employee band.

How does Intus Bio's funding compare to other Biotechnology startups?

Intus Bio's latest round of $1.1M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's Intus Bio Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Intus Bio is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.